Pawan Kumar

Company: Biomarin

Job title: Director

Bio:

Pawan Kumar, Ph.D., is Director of Oligonucleotide Chemistry at BioMarin Pharmaceutical. An experienced oligonucleotide and bioconjugate chemist, he has contributed extensively to therapeutic oligonucleotide development, with 59 research publications and 5 patent applications. Previously, he held senior roles at Takeda, focusing on oligonucleotide chemistry and delivery platforms. Dr. Kumar is a recipient of the H2020 Marie Curie Individual Fellowship and Humboldt Postdoctoral Fellowship, and holds a Ph.D. in Chemistry from Kurukshetra University. His expertise spans platform technologies, conjugation strategies, and preclinical oligonucleotide development.

Seminars:

Panel Discussion: Overcoming Design Challenges in Next-Generation Oligonucleotides to Maximize Selectivity, Potency & Clinical Impact 9:00 am

What design strategies are most effective in mitigating off-target effects? How do teams prioritize stability vs. delivery vs. potency? What are the emerging trends in oligonucleotide chemistry for next-generation therapeutics?Read more

day: Conference Day Two